JPH04194660A - Device for measuring concentration of component in blood - Google Patents
Device for measuring concentration of component in bloodInfo
- Publication number
- JPH04194660A JPH04194660A JP2326247A JP32624790A JPH04194660A JP H04194660 A JPH04194660 A JP H04194660A JP 2326247 A JP2326247 A JP 2326247A JP 32624790 A JP32624790 A JP 32624790A JP H04194660 A JPH04194660 A JP H04194660A
- Authority
- JP
- Japan
- Prior art keywords
- puncture needle
- electrode
- blood
- measuring device
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title abstract description 23
- 239000008280 blood Substances 0.000 title abstract description 23
- 108090000790 Enzymes Proteins 0.000 claims abstract description 58
- 102000004190 Enzymes Human genes 0.000 claims abstract description 58
- 238000002360 preparation method Methods 0.000 abstract description 3
- 229940088598 enzyme Drugs 0.000 description 55
- 239000012503 blood component Substances 0.000 description 25
- 238000005259 measurement Methods 0.000 description 23
- 239000012528 membrane Substances 0.000 description 22
- 238000004140 cleaning Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 239000012086 standard solution Substances 0.000 description 5
- 108010093096 Immobilized Enzymes Proteins 0.000 description 4
- 229920000557 Nafion® Polymers 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 239000011534 wash buffer Substances 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 238000003618 dip coating Methods 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000012482 calibration solution Substances 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 125000005909 ethyl alcohol group Chemical group 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000009719 polyimide resin Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
Abstract
Description
【発明の詳細な説明】
(イ)産業上の利用分野
この発明は、酵素電極を用いて血中の成分濃度を測定す
る測定器に関し、更に詳しく言えば、採血後ただちに血
中の生化学物質濃度が測定できる血中成分濃度測定器に
関する。Detailed Description of the Invention (a) Industrial Application Field The present invention relates to a measuring device that measures the concentration of components in blood using an enzyme electrode. This invention relates to a blood component concentration measuring device that can measure concentration.
(ロ)従来の技術
従来の酵素電極を用いた血中成分濃度測定器としては、
所謂ディスクリート方式或いはフロ一方式と呼ばれる構
成の臨床検査装置が知られている。(b) Conventional technology As a blood component concentration measuring device using a conventional enzyme electrode,
2. Description of the Related Art Clinical testing apparatuses having a configuration called a so-called discrete type or a flow type are known.
これらの装置は、試料の希釈、測定、装置の校正及び洗
浄がほぼ自動化されているか、装置が大型で高価であり
ランニングコストも高い。また、測定には長時間を要し
、多量の試料や緩衝液が必要である許かりでなく、装置
の取扱いには熟練を要し、装置の保守管理も煩雑であっ
た。In these devices, sample dilution, measurement, device calibration, and cleaning are almost automated, or the devices are large and expensive and have high running costs. In addition, measurement takes a long time, requires a large amount of samples and buffer solutions, requires skill in handling the device, and is complicated to maintain and manage the device.
そこで、近年、第6図に示すような簡易に測定できる血
中成分の濃度測定器が提案されている。Therefore, in recent years, a device for measuring the concentration of blood components that can be easily measured as shown in FIG. 6 has been proposed.
この血中成分の濃度測定器は、ケース体51に表示器5
2及び操作部53を設けると共に、脱着可能なカートリ
ッジ54を設けている。このカートリッジ54には、固
定化酵素膜55が支持されている。カートリッジ54を
ケース体51に装着することにより、このカートリッジ
54の下部に露出している下地電極(図示せず)に、酵
素膜55が密着されて酵素電極を構成するようになって
いる。This blood component concentration measuring device has a display 5 on a case body 51.
2 and an operation section 53, and a removable cartridge 54. An immobilized enzyme membrane 55 is supported on this cartridge 54 . By attaching the cartridge 54 to the case body 51, the enzyme membrane 55 is brought into close contact with a base electrode (not shown) exposed at the bottom of the cartridge 54, thereby forming an enzyme electrode.
血中成分の濃度の測定は、ランセットと称する突刺針(
図示せず)で、指先を突き刺し、−滴の静脈血を出血さ
せ、この一滴56を酵素膜55上に滴下する。そして、
酵素電極が濃度を測定した後に、血清56を拭き取る。The concentration of blood components is measured using a piercing needle called a lancet (
(not shown), prick the fingertip to draw a drop of venous blood, and drop this drop 56 onto the enzyme membrane 55. and,
After the enzyme electrode measures the concentration, the serum 56 is wiped off.
この時、標準液(校正用液)、緩衝液(洗浄用液)も同
様に滴下し拭き取る。At this time, the standard solution (calibration solution) and buffer solution (cleaning solution) are also dropped and wiped off.
(ハ)発明が解決しようとする課題
上記、近年提案されている血中成分濃度測定器では、小
型、且つ廉価であり、メンテナンスも不要である反面、
以下に列挙する問題点を有している。(c) Problems to be Solved by the Invention The blood component concentration measuring devices proposed in recent years as described above are small and inexpensive, and do not require maintenance.
It has the following problems.
■測定器本体と、この本体とは別体のランセットとを揃
えて用意しなければならない。また、血中成分の濃度測
定器を測定可能状態にセットした後に、ランセットで採
血しなけれはならず、操作手順が繁雑である。■The measuring device itself and a lancet, which is separate from the main body, must be prepared together. In addition, blood must be collected with a lancet after the blood component concentration measuring device is set in a measurable state, making the operating procedure complicated.
■ランセントで採血後、測定器本体まで指を移動する際
に、血液の落下を防止しなければならない。■After blood is drawn with the lancent, when moving the finger to the measuring device, it is necessary to prevent the blood from falling.
また、必ず酵素膜部分に一滴の血液を滴下しなければな
らない等、取扱いに細心の注意が必要である。In addition, careful handling is required, as one drop of blood must always be placed on the enzyme membrane.
■血液を酵素膜上に滴下する位置、及び滴下速度によっ
て測定値が異なる。また、酵素膜の全域を充分に満たす
にたる量の血液を滴下する必要があり、測定に細心の任
意が必要である。■Measurement values vary depending on the position where the blood is dropped onto the enzyme membrane and the dropping speed. In addition, it is necessary to drop blood in an amount sufficient to fully fill the entire area of the enzyme membrane, and measurement requires careful discretion.
■測定後或いは校正後の洗浄は、酵素膜に洗浄用緩衝液
を滴下し拭き取る操作を、繰り返し行うため煩雑であり
時間がかかる。また、下地電極表面に直接触れて拭き取
るため、下地電極表面に傷がつき破損しやすい。逆に、
拭き取りが不充分であると酵素膜上に液滴が残り、次の
測定に悪影響を与える。所謂、キャリーオーバーになり
、測定精度が劣化する。(2) Cleaning after measurement or calibration is complicated and time-consuming because the process of dropping a cleaning buffer onto the enzyme membrane and wiping it off is repeated. Furthermore, since the surface of the base electrode is directly touched and wiped off, the surface of the base electrode is easily scratched and damaged. vice versa,
If wiping is insufficient, droplets will remain on the enzyme membrane, which will adversely affect the next measurement. This results in so-called carryover, which deteriorates measurement accuracy.
■下地電極と酵素膜とが分離しているため、下地電極と
酵素膜との密着の程度が測定結果に反映し、測定精度の
劣化を招く。そこで、酵素膜を下地電極に装着する時に
、高い密着度を得ようとして、酵素膜の破損が頻発する
。また、下地電極表面は、酵素膜との密着性を高めるた
めに、凸面に加工しなければならず、製造コストが極め
て高い。■酵素膜の交換時には、下地電極表面に液を滴
下する等の繁雑な作業か必要である。また、この滴下液
量が測定結果に影響を与える。更に、交換後は暫く電極
出力が安定せず、測定可能になるまで時間がかかる。■Since the base electrode and the enzyme membrane are separated, the degree of close contact between the base electrode and the enzyme membrane is reflected in the measurement results, leading to deterioration of measurement accuracy. Therefore, when attaching the enzyme membrane to the base electrode, the enzyme membrane is frequently damaged in an attempt to obtain a high degree of adhesion. Furthermore, the surface of the base electrode must be processed into a convex surface in order to improve its adhesion to the enzyme membrane, resulting in extremely high manufacturing costs. ■When replacing the enzyme membrane, complicated work such as dropping liquid onto the surface of the underlying electrode is required. Moreover, the amount of the dropped liquid affects the measurement results. Furthermore, after replacement, the electrode output is not stable for a while, and it takes time until measurement is possible.
■下地電極破損の場合、下地電極がケース体に一体とな
っているため、交換が不可能であるう等の幾多の不利が
あった。(2) If the base electrode is damaged, there are many disadvantages such as the fact that it cannot be replaced because the base electrode is integrated with the case body.
この発明は、以上のような問題点に着目してなされたも
ので、測定器本体とランセット(突刺針)とを一体化す
ると共に、突刺針用キャップ体内に酵素電極を配備する
ことで、測定準備が簡便で取扱いが容易であり、測定精
度が高く安価な血中成分濃度測定器を提供することを目
的とする。This invention was made by focusing on the above-mentioned problems, and by integrating the measuring instrument body and a lancet (prick needle), and by disposing an enzyme electrode inside the cap body for the prick needle, measurement is possible. The purpose of the present invention is to provide a blood component concentration measuring device that is simple to prepare, easy to handle, has high measurement accuracy, and is inexpensive.
(ニ)課題を解決するための手段及び作用この目的を達
成させるために、この発明の血中成分濃度測定器では、
次のような構成としている。(d) Means and action for solving the problem In order to achieve this object, the blood component concentration measuring device of the present invention:
The structure is as follows.
血中成分濃度測定器は、測定器本体と、この測定器本体
の適所に脱着可能に取付けられた突刺針と、上記測定器
本体に対し脱着可能に嵌着され、前記突刺針をカバーす
る突刺針用キャップ体と、この突刺針用キャップ体に内
装配備され、外部に引き出された接続端部が上記測定器
本体のコネクタに接続される酵素電極とから成ることを
特徴としている。A blood component concentration measuring device includes a measuring device main body, a puncture needle detachably attached to an appropriate position of the measuring device body, and a puncture needle detachably fitted to the measuring device body and covering the puncture needle. It is characterized by comprising a needle cap body and an enzyme electrode which is disposed inside the puncture needle cap body and whose connecting end drawn out to the outside is connected to the connector of the measuring instrument main body.
このような構成を有する血中成分濃度測定器では、丸棒
状測定器本体の先端に突刺針が突設しである。一方、突
刺針用キャップ体はマイクロピペットのチップにもなる
円筒状ケースであり、このケース(キャップ体)の先端
部付近の内面には、接続端部を有する膜状の酵素電極が
配備しである。In a blood component concentration measuring device having such a configuration, a piercing needle is provided protruding from the tip of the round bar-shaped measuring device body. On the other hand, the puncture needle cap body is a cylindrical case that also serves as a micropipette tip, and a membrane-like enzyme electrode with a connecting end is arranged on the inner surface near the tip of this case (cap body). be.
そして、この酵素電極の接続端部を、測定器本体のコネ
クタに差し込むようになっている。突刺針は、測定器本
体のプランジャにより突刺針用キャップ体の先端側から
外方向へ突出可能になっている。従って、突出させた状
態で指先を突き刺す時、指先の血液は突刺針用キャンプ
体の内面の酵素電極に付着し、血中成分濃度が測定され
る。つまり、この測定器では突刺針と酵素電極と測定器
本体とが一体化している。従って、測定準備が簡便であ
り、マイクロピペットの操作により測定でき取扱いが容
易である。また、血清が付着した指を移動させることが
ないため、採血した試料を必ず測定に供することができ
る。更に、測定器本体のプランジャの操作で、標準液、
洗浄用緩衝液を供給、排出させるようにすることで、拭
き取り操作時に酵素電極に触れることがなく、酵素膜の
破損および下地電極の傷付きを防止できる。また、酵素
電極の交換は突刺針用キャンプ体の脱着により実行でき
籠便である。The connecting end of this enzyme electrode is then inserted into the connector of the main body of the measuring instrument. The puncture needle can be projected outward from the tip side of the puncture needle cap body by a plunger of the measuring device main body. Therefore, when the fingertip is pricked in the protruding state, the blood from the fingertip adheres to the enzyme electrode on the inner surface of the pricking needle camp, and the blood component concentration is measured. In other words, in this measuring device, the puncture needle, the enzyme electrode, and the measuring device body are integrated. Therefore, preparation for measurement is simple, and measurement can be performed by operating a micropipette, making it easy to handle. Furthermore, since the finger with serum attached thereto is not moved, the blood sample can always be used for measurement. Furthermore, by operating the plunger on the measuring instrument, standard solution,
By supplying and discharging the cleaning buffer, the enzyme electrode is not touched during the wiping operation, and damage to the enzyme membrane and damage to the base electrode can be prevented. In addition, the enzyme electrode can be replaced by attaching and detaching the puncture needle camp.
(ホ)実施例
第1図は、この発明δこ係る血中成分濃度測定器の具体
的な一実施例を示す斜視図である。(E) Embodiment FIG. 1 is a perspective view showing a specific embodiment of the blood component concentration measuring device according to the present invention.
血中成分濃度測定器は、測定器本体1と、この測定器本
体1の適所に脱着可能に取付けられた突刺針3と、上記
測定器本体1に対し脱着可能に嵌着され、前記突刺針3
をカバーする突刺針用キャップ体2と、この突刺針用キ
ャンプ体2に内装配備され、接続端部が上記測定器本体
1のコネクタ14に接続される酵素電極4とから構成さ
れる。The blood component concentration measuring device includes a measuring device main body 1, a puncture needle 3 removably attached to a proper position of the measuring device main body 1, and a puncture needle 3 that is removably fitted to the measuring device main body 1. 3
The cap body 2 for the puncture needle covers the cap body 2 for the puncture needle, and the enzyme electrode 4 is disposed inside the camp body 2 for the puncture needle and has a connection end connected to the connector 14 of the measuring device main body 1.
測定器本体1は、丸棒状のベンタイプに形成され、内部
に図示はしないが血中成分定量手段(酵素電極の出力に
より血中成分の濃度を定量する手段)を備えると共に、
外部適所に表示器(液晶表示器)Itと操作部12を配
備している。また、後端部にはプランジャ13が配備し
である。更に、第3図で示すように、測定器本体1の先
端側には、後述する酵素電極4の接続端部41aが挿し
こまれ、定量手段と接続するためのコ茅りタ14が設け
である。The measuring device main body 1 is formed into a round bar-shaped vent type, and is equipped with blood component determination means (means for determining the concentration of blood components by the output of the enzyme electrode), although not shown inside.
A display (liquid crystal display) It and an operation section 12 are provided at appropriate external locations. Further, a plunger 13 is provided at the rear end. Furthermore, as shown in FIG. 3, a connecting end 41a of an enzyme electrode 4, which will be described later, is inserted into the distal end side of the main body 1 of the measuring device, and a connector 14 is provided for connecting it to a quantitative means. be.
上記突刺針(ランセント〕3は、第3図で示すように、
測定器本体lの先端部に保持部15を介して脱着可能に
突出状に取付けられている。この突刺針3は、ハネ機構
等の進退手段(図示せず)を介して上記プランジャ13
に連繋され、プランジャ13の操作で後述する突刺針用
キャップ体2の先端側より外方へ突出可能に配備されて
いる。As shown in FIG. 3, the piercing needle (Lancet) 3 is
It is removably attached to the distal end of the measuring instrument body l via a holding part 15 in a protruding manner. This puncture needle 3 is inserted into the plunger 13 through a reciprocating means (not shown) such as a spring mechanism.
The needle cap body 2 is connected to the plunger 13, and is arranged so as to be able to protrude outward from the distal end side of the puncture needle cap body 2, which will be described later, by operating the plunger 13.
前記突刺針用キャップ体2は、第2図で示すように、測
定器本体1の先端部に脱着可能に嵌着するケース体で、
マイクロピペットのチップにもなる円筒状ケースである
。この突刺針用キャップ体2は、両端が開口しており、
先端側間口22か上記突刺針3の出没用孔部となってい
る。また、上記プランジャ13には、図示はしないが、
このマイクロピペットの千ノブでもある円筒状ケース(
キャンプ体)2に対し、血液、標準液、洗浄用緩衝液を
供給 排出させる機能を有するように設定しである。つ
まり、2段階で出没するプランジャ13は、第1段階の
押し操作で突刺針3が突出し、第2段階の押し操作で標
準液、洗浄用緩衝液が供給・排出されるように構成しで
ある(図示せず)。As shown in FIG. 2, the puncture needle cap body 2 is a case body that is removably fitted to the tip of the measuring instrument body 1.
It is a cylindrical case that can also be used as a micropipette tip. This puncture needle cap body 2 is open at both ends,
The front end side opening 22 serves as a hole for the puncture needle 3 to enter and exit. Furthermore, although not shown in the drawings, the plunger 13 includes:
The cylindrical case that is also the thousand knobs of this micropipette (
It is designed to have the function of supplying and discharging blood, standard solution, and washing buffer solution to the camp body) 2. In other words, the plunger 13, which comes and goes in two stages, is configured such that the puncture needle 3 protrudes in the first stage of the push operation, and the standard solution and washing buffer are supplied and discharged in the second stage of the push operation. (not shown).
上記酵素電極4は、第4図及び第5図で示すように、突
刺針用キャンプ体2の内面適所に配備されている。この
酵素電極4は、電極支持基板41と、作用電極42及び
対照電極43(この画電極42.43で下地電極が構成
される)と、絶縁性保護膜44と、固定化酵素膜45と
から成る。電極支持基板41は、プラスチックフィルム
等の絶縁材で、この電極支持基板41上に作用電極42
、対照電極43が形成される。この下地電極は、スパン
クリング、真空蒸着、イオンブレーティング等の手段を
適用して、白金を膜形成したものである。尚、下地電極
の電極材料としては、白金に限定されるものではなく、
形成手段もメンキ箔の貼着等適宜変更可能である。更に
、この電極支持基板41上には、接続端部41aを除い
て絶縁保護膜44が形成されると共に、作用電極42、
対照電極43が、それぞれ感応部42b、43b、接続
部42a、43aを除いて被覆される。絶縁保護膜44
は、感光性ポリイミド樹脂を用い、ホトリソグラフィー
を利用して感応部を規定する。また、この絶縁保護膜4
4上には、固定化酵素膜45が形成される。この固定化
酵素If!J45は、ナフィオン層45a1酵素層45
b、ナフィオン層45Cを積層した三層構造である。ナ
フィオンは、アメリカ・デュポン社の商品名で、正しく
はP。As shown in FIGS. 4 and 5, the enzyme electrode 4 is placed at a suitable position on the inner surface of the puncture needle camp 2. The enzyme electrode 4 includes an electrode support substrate 41, a working electrode 42, a reference electrode 43 (the picture electrodes 42 and 43 constitute a base electrode), an insulating protective film 44, and an immobilized enzyme film 45. Become. The electrode support substrate 41 is made of an insulating material such as a plastic film, and the working electrode 42 is placed on this electrode support substrate 41.
, a control electrode 43 is formed. This base electrode is formed by forming a platinum film by applying means such as span ring, vacuum evaporation, and ion blating. Note that the electrode material for the base electrode is not limited to platinum,
The forming means can also be changed as appropriate, such as by attaching menki foil. Furthermore, an insulating protective film 44 is formed on this electrode support substrate 41 except for the connection end 41a, and a working electrode 42,
A reference electrode 43 is covered except for the sensitive parts 42b, 43b and the connecting parts 42a, 43a, respectively. Insulating protective film 44
uses a photosensitive polyimide resin and defines the sensitive area using photolithography. In addition, this insulating protective film 4
4, an immobilized enzyme membrane 45 is formed. This immobilized enzyme If! J45 is Nafion layer 45a1 enzyme layer 45
b. It has a three-layer structure in which Nafion layers 45C are laminated. Nafion is a product name of the American company DuPont, and its correct name is P.
1yperfluorosulfuric acid
で、陽イオン交換性の高分子である。このナフィオンは
、5%溶液(溶媒はエチルアルコール)が市販されてお
り、膜形成は容易である。実施例では、デイツプコーテ
ィングにより膜形成している。酵素層45bは、酵素液
よりデイツプコーティングして膜形成している。酵素液
は、0.1モルのリン酸緩衝液(pH6,0)に、グル
コースオキシダーゼ(COD)10%、牛血清アルブミ
ン(BSA)7.5%及びグリタルアルデヒド0.5%
の濃度になるように調整したものである。このような構
成の酵素電極4は、突刺針キャンプ体2内周面に接着剤
等で貼着される。この際、接続端部41aが突刺針用キ
ャップ体2外部に露出し、作用電極42、対照電極43
の接続端部42a、43aが、測定器本体1のコネクタ
14に接続し得るようなっている(第3図参照)。1yperfluorosulfuric acid
It is a cation exchange polymer. This Nafion is commercially available as a 5% solution (the solvent is ethyl alcohol), and it is easy to form a film. In the examples, the film is formed by dip coating. The enzyme layer 45b is formed by dip coating with an enzyme solution. The enzyme solution was 0.1M phosphate buffer (pH 6.0), 10% glucose oxidase (COD), 7.5% bovine serum albumin (BSA), and 0.5% glitaraldehyde.
It was adjusted to have a concentration of . The enzyme electrode 4 having such a configuration is attached to the inner peripheral surface of the puncture needle camp body 2 with an adhesive or the like. At this time, the connection end 41a is exposed to the outside of the puncture needle cap body 2, and the working electrode 42 and the control electrode 43
The connecting ends 42a, 43a of the measuring device 1 can be connected to the connector 14 of the measuring device main body 1 (see FIG. 3).
このような構成を有する血中成分濃度測定器により、血
中成分の濃度を測定する場合は、突刺針用キャップ体2
が装着された測定器本体1を、突刺針用キャップ体2の
端面2aが指先表面に密着するように押し付ける。そし
て、2段操作になっているプランジャ13の第1段を押
すことにより、突刺針3が突刺針用キャップ体(開口孔
22)2先端より突出し、皮膚面を出血させる。この血
液が、突刺針用キャップ体2内面の酵素電極4に接する
ことで測定が可能となる。酵素電極4の酵素膜45に血
液が接すると、酵素膜45内で酵素グルコースオキシダ
ーゼ(COD)による次式の反応が生しる。When measuring the concentration of blood components with a blood component concentration measuring device having such a configuration, the puncture needle cap body 2
The measuring device main body 1 with the attached is pressed so that the end surface 2a of the puncture needle cap body 2 comes into close contact with the fingertip surface. Then, by pushing the first stage of the plunger 13, which is operated in two stages, the puncture needle 3 protrudes from the tip of the puncture needle cap body (opening hole 22) 2, causing bleeding on the skin surface. Measurement becomes possible when this blood comes into contact with the enzyme electrode 4 on the inner surface of the puncture needle cap body 2. When blood comes into contact with the enzyme membrane 45 of the enzyme electrode 4, the following reaction by the enzyme glucose oxidase (COD) occurs within the enzyme membrane 45.
この時、生成した過酸化水素(H20□)は、作用電極
42aの惑応部42bで酸化され、この酸化電流が電極
出力となる。この電極出力から化学量論的に、血液中の
グルコース濃度を知ることができる。測定が終了したら
、プランジャ13の第2段を押して血液を排出し、プラ
ンジャ13の操作により洗浄用緩衝液を供・排出し、酵
素電極4を洗浄する。また、突刺針3の交換は測定器本
体1より突刺針用キャップ体2を外して行う(第3回参
照)。At this time, the generated hydrogen peroxide (H20□) is oxidized in the perturbation portion 42b of the working electrode 42a, and this oxidation current becomes the electrode output. From this electrode output, the glucose concentration in the blood can be determined stoichiometrically. When the measurement is completed, the second stage of the plunger 13 is pushed to drain the blood, and the plunger 13 is operated to supply and drain the cleaning buffer, thereby cleaning the enzyme electrode 4. Furthermore, the puncture needle 3 is replaced by removing the puncture needle cap body 2 from the measuring device main body 1 (see Part 3).
上記実施例では、酵素としてCODを固定化し、血液中
のグリコース濃度を定量する構成としているが、他の酵
素を用いてグルコース以外の血液成分の濃度を定量する
ことも可能であり、適宜設計変更可能である。In the above example, COD is immobilized as an enzyme to quantify the glucose concentration in the blood, but it is also possible to quantify the concentration of blood components other than glucose using other enzymes, and the design can be changed as appropriate. It is possible.
(へ)発明の効果
この発明では、以上のような構成としたから、次に列挙
するような効果を有する。(F) Effects of the Invention Since the present invention has the above configuration, it has the following effects.
■ランセットと酵素電極が一本の測定器に共に設けられ
ているので測定準備が簡便であり、マイクロピペットの
操作で測定できるから取扱いが容易である。■Since a lancet and an enzyme electrode are provided together in one measuring device, preparation for measurement is simple, and measurement can be performed by operating a micropipette, making handling easy.
■また、血的が付着した指を移動させることかないため
、採血した試料を必ず測定に供することができる。-Furthermore, since there is no need to move the finger with blood on it, the blood sample can always be used for measurement.
■拭き取り操作などで酵素電極に触れることがないので
、酵素膜の破損は皆無であり、下地電極を傷つけること
がない。■Since the enzyme electrode is not touched during the wiping operation, there is no damage to the enzyme membrane and no damage to the base electrode.
■酵素電極は構造が簡単で量産でき、低価格で提供でき
るから使い捨て使用ができる。■Enzyme electrodes have a simple structure, can be mass-produced, and can be provided at a low price, making them disposable.
■洗浄用緩衝液等の排出は、マイクロピペットの排出動
作により行うため、酵素電極上に液滴が残存しない。従
って、キャリーオーバが防止でき高い測定精度が達成で
きる。■Since the washing buffer solution, etc. is discharged by the discharge operation of a micropipette, no droplets remain on the enzyme electrode. Therefore, carryover can be prevented and high measurement accuracy can be achieved.
■酵素膜か下地電極に一体に被覆されているため、酵素
膜と下地電極との密着度が一定しており、再現性に優れ
た測定を行うことができる。■Since the enzyme membrane is integrally coated with the base electrode, the degree of adhesion between the enzyme membrane and the base electrode is constant, making it possible to perform measurements with excellent reproducibility.
■また、酵素膜のみの交換は不要であり、下地電極の拭
き取り等、細心の注意を要する作業が解消される。■Also, there is no need to replace only the enzyme membrane, eliminating work that requires careful attention, such as wiping the underlying electrode.
■酵素電極の交換は、突刺針用キャンプ体の脱着により
行え、交換作業が容易である。■The enzyme electrode can be replaced by attaching and detaching the puncture needle camp, making it easy to replace.
■血液の他には、小量の洗浄用緩衝液と標準液が必要な
だけであり、拭き取り用具も不要でランニングコストも
軽減される。■In addition to blood, only a small amount of washing buffer and standard solution are required, and no wiping tools are required, reducing running costs.
等の優れた効果を有する。It has excellent effects such as
第1図は、実施例血中成分濃度測定器を示す斜視図、第
2図は、実施例血中成分濃度測定器の突刺針用キャップ
体の断面図、第3図は、実施例血中成分濃度測定器の突
刺針用キャップ体を外した状態を示す斜視図、第4図は
、実施例血中成分濃度測定器の酵素電極を示す要部縦断
面図、第5図は、実施例血中成分濃度測定器の酵素電極
を示す要部横断面図、第6図は、従来の血中成分濃度測
定器を示す斜視図である。
1;測定器本体、 2:突刺針用キヤ、7プ体、3:
突刺針、 4:酵素電極、
14:コネクタ、 41a:接続端部。
特許出願人 オムロン株式会社代理人
弁理士 中 村 茂 信第1図
/
第2図
第4図
第6図FIG. 1 is a perspective view showing an example blood component concentration measuring device, FIG. 2 is a cross-sectional view of a puncture needle cap body of the example blood component concentration measuring device, and FIG. 3 is a perspective view showing an example blood component concentration measuring device. FIG. 4 is a longitudinal cross-sectional view of a main part showing the enzyme electrode of the blood component concentration measuring device according to the embodiment; FIG. 5 is a perspective view showing the component concentration measuring device with the needle cap removed; FIG. 6 is a cross-sectional view of a main part showing an enzyme electrode of a blood component concentration measuring device, and FIG. 6 is a perspective view showing a conventional blood component concentration measuring device. 1; Measuring instrument body, 2: Needle carrier, 7-piece body, 3:
Pierce needle, 4: Enzyme electrode, 14: Connector, 41a: Connection end. Patent applicant OMRON Co., Ltd. agent
Patent Attorney Shigeru Nakamura Figure 1/ Figure 2 Figure 4 Figure 6
Claims (1)
に取付けられた突刺針と、上記測定器本体に対し脱着可
能に嵌着され、前記突刺針をカバーする突刺針用キャッ
プ体と、この突刺針用キャップ体に内装配備され、外部
に引き出された接続端部が上記測定器本体のコネクタに
接続される酵素電極とから成る血中成分濃度測定器。(1) A measuring instrument main body, a puncture needle detachably attached to a suitable position on the measuring instrument main body, and a puncture needle cap body detachably fitted to the measuring instrument body and covering the puncture needle. and an enzyme electrode disposed inside the puncture needle cap body, the connecting end of which is pulled out to the outside and connected to the connector of the measuring device main body.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2326247A JPH04194660A (en) | 1990-11-27 | 1990-11-27 | Device for measuring concentration of component in blood |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2326247A JPH04194660A (en) | 1990-11-27 | 1990-11-27 | Device for measuring concentration of component in blood |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04194660A true JPH04194660A (en) | 1992-07-14 |
Family
ID=18185641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2326247A Pending JPH04194660A (en) | 1990-11-27 | 1990-11-27 | Device for measuring concentration of component in blood |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04194660A (en) |
Cited By (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837199A (en) * | 1994-08-05 | 1998-11-17 | Institut Fur Chemo-Und Biosensorik Munster E.V. | Measurement apparatus for analyzing fluids |
US6607658B1 (en) | 1997-02-06 | 2003-08-19 | Therasense, Inc. | Integrated lancing and measurement device and analyte measuring methods |
US6699382B2 (en) | 1998-06-11 | 2004-03-02 | Matsushita Electric Industrial Co., Ltd. | Method for analyzing a biological sample |
US6706159B2 (en) * | 2000-03-02 | 2004-03-16 | Diabetes Diagnostics | Combined lancet and electrochemical analyte-testing apparatus |
EP1262768A4 (en) * | 2000-12-13 | 2004-06-30 | Matsushita Electric Ind Co Ltd | Analytical element, and measuring instrument and substrate determining method using the same |
JP2006314831A (en) * | 2006-07-31 | 2006-11-24 | Arkray Inc | Lancet integrated body liquid measurement apparatus and mounted body used by mounting thereon |
JP2007020704A (en) * | 2005-07-13 | 2007-02-01 | National Institute Of Advanced Industrial & Technology | Needle-integrated biosensor |
US7288073B2 (en) | 2001-07-20 | 2007-10-30 | Roche Diagnostics Operations, Inc. | System for withdrawing small amounts of body fluid |
US8123701B2 (en) | 1996-05-17 | 2012-02-28 | Roche Diagnostics Operations, Inc. | Methods and apparatus for sampling and analyzing body fluid |
US8383041B2 (en) | 2002-12-23 | 2013-02-26 | Roche Diagnostics Operations, Inc. | Body fluid testing device |
WO2013069223A1 (en) * | 2011-11-08 | 2013-05-16 | パナソニック株式会社 | Biological information measurement cartridge and measurement device using same |
US8696596B2 (en) | 1996-05-17 | 2014-04-15 | Roche Diagnostics Operations, Inc. | Blood and interstitial fluid sampling device |
US8740813B2 (en) | 1996-05-17 | 2014-06-03 | Roche Diagnostics Operations, Inc. | Methods and apparatus for expressing body fluid from an incision |
US8845550B2 (en) | 2001-06-12 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8845549B2 (en) | 2002-04-19 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Method for penetrating tissue |
US8905945B2 (en) | 2002-04-19 | 2014-12-09 | Dominique M. Freeman | Method and apparatus for penetrating tissue |
US8945910B2 (en) | 2003-09-29 | 2015-02-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8986223B2 (en) | 2001-06-08 | 2015-03-24 | Roche Diagnostics Operations, Inc. | Test media cassette for bodily fluid testing device |
US9034250B2 (en) | 2005-03-02 | 2015-05-19 | Roche Diagnostics Operations, Inc. | Dynamic integrated lancing test strip with sterility cover |
US9034639B2 (en) | 2002-12-30 | 2015-05-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US9060727B2 (en) | 2002-11-06 | 2015-06-23 | Abbott Diabetes Care Inc. | Automatic biological analyte testing meter with integrated lancing device and methods of use |
US9089678B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9089294B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9215993B2 (en) | 2001-08-29 | 2015-12-22 | Roche Diagnostics Operations, Inc. | Analytical device with lancet and test element |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US9234863B2 (en) | 1998-10-08 | 2016-01-12 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9261476B2 (en) | 2004-05-20 | 2016-02-16 | Sanofi Sa | Printable hydrogel for biosensors |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9561000B2 (en) | 2003-12-31 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US9560993B2 (en) | 2001-11-21 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9839386B2 (en) | 2002-04-19 | 2017-12-12 | Sanofi-Aventis Deustschland Gmbh | Body fluid sampling device with capacitive sensor |
US9839387B2 (en) | 2000-10-31 | 2017-12-12 | Roche Diabetes Care, Inc. | System for withdrawing blood |
US9901296B2 (en) | 2000-03-04 | 2018-02-27 | Roche Diabetes Care, Inc. | Blood lancet with hygienic tip protection |
-
1990
- 1990-11-27 JP JP2326247A patent/JPH04194660A/en active Pending
Cited By (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837199A (en) * | 1994-08-05 | 1998-11-17 | Institut Fur Chemo-Und Biosensorik Munster E.V. | Measurement apparatus for analyzing fluids |
US8690798B2 (en) | 1996-05-17 | 2014-04-08 | Roche Diagnostics Operations, Inc. | Methods and apparatus for sampling and analyzing body fluid |
US8123701B2 (en) | 1996-05-17 | 2012-02-28 | Roche Diagnostics Operations, Inc. | Methods and apparatus for sampling and analyzing body fluid |
US8231549B2 (en) | 1996-05-17 | 2012-07-31 | Roche Diagnostics Operations, Inc. | Methods and apparatus for sampling and analyzing body fluid |
US8696596B2 (en) | 1996-05-17 | 2014-04-15 | Roche Diagnostics Operations, Inc. | Blood and interstitial fluid sampling device |
US8740813B2 (en) | 1996-05-17 | 2014-06-03 | Roche Diagnostics Operations, Inc. | Methods and apparatus for expressing body fluid from an incision |
US6607658B1 (en) | 1997-02-06 | 2003-08-19 | Therasense, Inc. | Integrated lancing and measurement device and analyte measuring methods |
US7335294B2 (en) | 1997-02-06 | 2008-02-26 | Abbott Diabetes Care, Inc. | Integrated lancing and measurement device and analyte measuring methods |
JP2007268289A (en) * | 1997-02-06 | 2007-10-18 | Therasense Inc | Small volume in vitro analyte sensor |
US9234864B2 (en) | 1997-02-06 | 2016-01-12 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
JP2012101092A (en) * | 1997-02-06 | 2012-05-31 | Abbott Diabetes Care Inc | Small volume in vitro analyte sensor |
US6699382B2 (en) | 1998-06-11 | 2004-03-02 | Matsushita Electric Industrial Co., Ltd. | Method for analyzing a biological sample |
US9234863B2 (en) | 1998-10-08 | 2016-01-12 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9291592B2 (en) | 1998-10-08 | 2016-03-22 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9341591B2 (en) | 1998-10-08 | 2016-05-17 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9891185B2 (en) | 1998-10-08 | 2018-02-13 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9316609B2 (en) | 1998-10-08 | 2016-04-19 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US7378007B2 (en) | 2000-03-02 | 2008-05-27 | Diabetes Diagnostics, Inc. | Combined lancet and electrochemical analyte-testing apparatus |
US6706159B2 (en) * | 2000-03-02 | 2004-03-16 | Diabetes Diagnostics | Combined lancet and electrochemical analyte-testing apparatus |
US9901296B2 (en) | 2000-03-04 | 2018-02-27 | Roche Diabetes Care, Inc. | Blood lancet with hygienic tip protection |
US9839387B2 (en) | 2000-10-31 | 2017-12-12 | Roche Diabetes Care, Inc. | System for withdrawing blood |
US10617340B2 (en) | 2000-10-31 | 2020-04-14 | Roche Diabetes Care, Inc. | System for withdrawing blood |
US6878262B2 (en) | 2000-12-13 | 2005-04-12 | Matsushita Electric Industrial Co., Ltd. | Analytical element and measuring device and substrate quantification method using the same |
EP1262768A4 (en) * | 2000-12-13 | 2004-06-30 | Matsushita Electric Ind Co Ltd | Analytical element, and measuring instrument and substrate determining method using the same |
US8986223B2 (en) | 2001-06-08 | 2015-03-24 | Roche Diagnostics Operations, Inc. | Test media cassette for bodily fluid testing device |
US8845550B2 (en) | 2001-06-12 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9802007B2 (en) | 2001-06-12 | 2017-10-31 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9694144B2 (en) | 2001-06-12 | 2017-07-04 | Sanofi-Aventis Deutschland Gmbh | Sampling module device and method |
US7288073B2 (en) | 2001-07-20 | 2007-10-30 | Roche Diagnostics Operations, Inc. | System for withdrawing small amounts of body fluid |
US7993284B2 (en) | 2001-07-20 | 2011-08-09 | Roche Diagnostics Operations, Inc. | System for withdrawing small amounts of body fluid |
US8388552B2 (en) | 2001-07-20 | 2013-03-05 | Roche Diagnostics Operations, Inc. | System for withdrawing small amounts of body fluid |
US8821413B2 (en) | 2001-07-20 | 2014-09-02 | Roche Diagnostics Operations, Inc. | System for withdrawing small amounts of body fluid |
US9215993B2 (en) | 2001-08-29 | 2015-12-22 | Roche Diagnostics Operations, Inc. | Analytical device with lancet and test element |
US9560993B2 (en) | 2001-11-21 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US9186468B2 (en) | 2002-04-19 | 2015-11-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9724021B2 (en) | 2002-04-19 | 2017-08-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9089294B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US8845549B2 (en) | 2002-04-19 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Method for penetrating tissue |
US9072842B2 (en) | 2002-04-19 | 2015-07-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US9839386B2 (en) | 2002-04-19 | 2017-12-12 | Sanofi-Aventis Deustschland Gmbh | Body fluid sampling device with capacitive sensor |
US9089678B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9498160B2 (en) | 2002-04-19 | 2016-11-22 | Sanofi-Aventis Deutschland Gmbh | Method for penetrating tissue |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8905945B2 (en) | 2002-04-19 | 2014-12-09 | Dominique M. Freeman | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9907502B2 (en) | 2002-04-19 | 2018-03-06 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9339612B2 (en) | 2002-04-19 | 2016-05-17 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9060727B2 (en) | 2002-11-06 | 2015-06-23 | Abbott Diabetes Care Inc. | Automatic biological analyte testing meter with integrated lancing device and methods of use |
US8574496B2 (en) | 2002-12-23 | 2013-11-05 | Roche Diagnostics Operations, Inc. | Body fluid testing device |
US8383041B2 (en) | 2002-12-23 | 2013-02-26 | Roche Diagnostics Operations, Inc. | Body fluid testing device |
US9034639B2 (en) | 2002-12-30 | 2015-05-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US8945910B2 (en) | 2003-09-29 | 2015-02-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
US9561000B2 (en) | 2003-12-31 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US9261476B2 (en) | 2004-05-20 | 2016-02-16 | Sanofi Sa | Printable hydrogel for biosensors |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9034250B2 (en) | 2005-03-02 | 2015-05-19 | Roche Diagnostics Operations, Inc. | Dynamic integrated lancing test strip with sterility cover |
US9445756B2 (en) | 2005-03-02 | 2016-09-20 | Roche Diabetes Care, Inc. | Dynamic integrated lancing test strip with sterility cover |
JP2007020704A (en) * | 2005-07-13 | 2007-02-01 | National Institute Of Advanced Industrial & Technology | Needle-integrated biosensor |
JP4635140B2 (en) * | 2006-07-31 | 2011-02-16 | アークレイ株式会社 | Lancet-integrated body fluid measuring device and attached body to be used by attaching to this body fluid measuring device |
JP2006314831A (en) * | 2006-07-31 | 2006-11-24 | Arkray Inc | Lancet integrated body liquid measurement apparatus and mounted body used by mounting thereon |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
WO2013069223A1 (en) * | 2011-11-08 | 2013-05-16 | パナソニック株式会社 | Biological information measurement cartridge and measurement device using same |
US10258263B2 (en) | 2011-11-08 | 2019-04-16 | Phc Holdings Corporation | Biological information measurement cartridge and measurement device using same |
JPWO2013069223A1 (en) * | 2011-11-08 | 2015-04-02 | パナソニックヘルスケアホールディングス株式会社 | Biological information measuring cartridge and measuring apparatus using the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH04194660A (en) | Device for measuring concentration of component in blood | |
US5753429A (en) | Analyte concentration measurement using a hollow frustum | |
KR100544038B1 (en) | Remote-Dose Analyte Concentration Meter | |
US5846486A (en) | Hollow frustum reagent test device | |
US7147825B2 (en) | Measuring system | |
US6099802A (en) | Hollow frustum reagent test device | |
US7771368B2 (en) | Body fluid collecting device | |
US8399259B2 (en) | Measuring device, measuring apparatus and method of measuring | |
JP2000146961A (en) | Test piece for analyzing humor sample and reading by detecting device | |
JPWO2002048703A1 (en) | Analytical element, measuring instrument and substrate quantification method using the same | |
JP2004000600A (en) | Physiological sampling apparatus and method for using the sample | |
JP4411276B2 (en) | Body fluid collection tool | |
US20030077205A1 (en) | Diagnostic test optical fiber tips | |
CN109540881A (en) | A kind of analoids | |
JPH04248457A (en) | Biochemical substance measuring equipment | |
JPH11326262A (en) | Biosensor | |
JPH04254748A (en) | Measuring device of biochemical substance | |
JP2004004057A (en) | Biosensor, adapter used for the same and measuring apparatus | |
JP2001245872A (en) | Auxiliary tool | |
JP2004194926A (en) | Humor collecting equipment | |
JPH04215056A (en) | Biochemical material measuring apparatus | |
JPH0572169A (en) | Biochemical substance measuring device | |
US20130102065A1 (en) | Small Volume and Fast Acting Optical Analyte Sensor |